[ad_1]
The American company Moderna announced an agreement to provide Australia with 25 million doses of COVID-19 vaccine in 2021 and 2022.
The American company Moderna announced a new supply agreement with Australia to supply its 25 million doses of COVID-19 vaccine.
The biotech company said this will include 10 million doses of lancets against the original “ancestral” coronavirus strain in 2021, and 15 million doses of its variant-enhanced vaccine candidate in 2022.
The company said in a press release that the agreement has yet to be approved by the Therapeutic Drug Administration (TGA) for messenger RNA vaccines and enhanced drug candidates.
Stéphane Bancel, CEO of Moderna, said: “We are very pleased to have reached a partnership with the Australian government and have obtained the first dose of Moderna COVID-19 vaccine and our alternative booster vaccine candidate supply agreement.
related: Proposal for mass production of SA facilities prodded by Pfizer and Moderna
“As we seek to use the COVID-19 vaccine and possible variant booster vaccine candidates to protect people around the world, we look forward to continuing discussions with Australia on how to establish potential local manufacturing opportunities.
A spokesperson for Prime Minister Scott Morrison did not immediately respond to news.com.au’s request for comment.
The World Health Organization added Modern Moab As the world is struggling with global supply issues, more and more emergency vaccines were approved on May 2.
The US Food and Drug Administration authorized the emergency use of Moderna vaccine on December 18, 2020. The lancet is also authorized in Canada, Israel, the European Union, the United Kingdom, Switzerland, Singapore, Qatar, Taiwan, the Philippines and Brunei. It is currently under review in other countries.
The vaccine was administered in two doses, and it was reported that it was 94.1% effective after the second dose.
related: Call for Australia to change its vaccination method
It uses the same method as Pfizer to extract and protect the gene fragment of the coronavirus spike protein in oily pods so that it can be delivered to our cells.
Our immune system will see the subsequent spikes, indicating that we have been infected and have begun to defend, establishing a response to the real disease.
The Prime Minister of South Australia Steven Marshall has talked with the Minister of Health Greg Hunt (Greg Hunt) about production recommendations Pfizer and Moderna vaccine A factory in the state. The manufacturing plant in Thebarton in the inner west of Adelaide has the capacity to mass-produce mRNA vaccines within 12 months.
Only two vaccines are currently approved for use in Australia: Pfizer/BioNTech Prick and Oxford/AstraZeneca.
Australia only delivers 2.66 million doses Vaccination is administered to more than 25 million people, and 400,000 people are currently vaccinated every week.
The launch was not only affected by supply issues, but also by reports in the following areas: Blood clots in people who were prodded by AstraZenecaNow Pfizer vaccine has become the first choice for children under 50.
[ad_2]
Source link